

Cardiothoracic Surgery
Vice President of West China Hospital, Sichuan University Fellow of the RCS, Member of AATS, Program Committee Member of ESTS, Vice Chair of the CSTCS, Leader of CSTCS, Vice Chair of the CATS, Leader of Lung Surgery Group of CATS
Professor Lunxu Liu is the Executive Vice President, West China Hospital of Sichuan University. He received his MD degree and PhD degree at West China University of Medical Sciences. He is considered a pioneer in performing complete video-assisted thoracic surgery (VATS) for lung cancer in Mainland China. He raised the concept of “single-direction VATS lobectomy”, which made VATS lobectomy more concise and easier to learn and was widely used by most Chinese thoracic surgeons. He developed the novel method of “suction-compressing angiorrhaphy technique (SCAT)” for troubleshooting vascular injury during anatomic thoracoscopic pulmonary resection without conversion to thoracotomy. He also completed the first series of thoracoscopic bronchovascular double-sleeve lobectomy in the world. As project leader, professor Liu received the first prize of Sichuan Province Science and Technology Progress Award and Chinese Medical Science and Technology Award, respectively, for his great efforts and achievements in minimally invasive thoracic surgery. Professor Liu is currently a Fellow of The Royal College of Surgeons (RCS). He serves as Vice-chair of Chinese Association of Thoracic Surgeon (CATS). He is also Chair of the Experts Committee on Minimally Invasive Surgery of CATS. Meanwhile, he is Deputy Leader of both Thoracoscopic Surgery Study Group and Lung Cancer Study Group of the Chinese Society for Thoracic and Cardiovascular Surgery. Besides, he has also taken up several leadership roles in multiple academic societies. Professor Liu’s major clinical and research interests include minimally invasive thoracic surgery and lung cancer. He has been in charge of more than 10 projects funded by Natural Science Foundation of China (NSFC) and other foundations. He has authored or co-authored more than 100 peer-reviewed articles and textbook chapters. He also sits on the Editorial Board of Thoracic Cancer, Journal of Thoracic Disease, and several other academic journals. He has served as a chairman and member of the program committee for multiple international or national meetings, and he has delivered more than 30 live operation demonstrations at these meetings.
Selected publications from PubMed
Generation of two homozygous iPSC lines carrying variants of uncertain significance in LMNA associated with cardiomyopathy.
Liu L, Wu D, Manhas A, Noishiki C, Tripathi D, Sadat S, Bharucha N, Karakikes I, Sallam K, Sayed N
Stem Cell Res. 2026 Sep;95:104086 doi: 10.1016/j.scr.2026.104086.
RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.
Wu D, Tripathi D, Manhas A, Noishiki C, Liu L, Wu CA, Venkateshappa R, Zhang H, Ren L, Thomas D, Nalbandian M, Limbu L, DaValle CC, Rangan ES, Nallamshetty S, Boyd JH, Malik SB, Woo YJ, Sayed D, Sallam K, Blau HM, Wu JC, Sayed N
Eur Heart J. 2026 Aug 11 pii: ehag619. doi: 10.1093/eurheartj/ehag619.
Epidemiological characteristics and risk factors of lung cancer in a population with incidental pulmonary nodules in China: a prospective multicenter study of 10,560 cases.
Liang W, Zhou Y, Hu C, Xiao W, Zhang J, Li M, Wang W, Ye X, Zhang X, Chang N, Yun C, Sun D, Zhang Y, Qin Z, Wang W, Zhang Y, Zhang X, Xiang Y, Qu J, Zhang W, Sun L, Hu Y, Xu J, Wu D, Zhao J, Zhang X, Bao H, Liu X, Guo Y, Li Z, Zhang Q, Zhu W, Yang L, Dang X, Han B, Tong Z, Wang F, Liu L, Peng M, Wu S, Zeng L, Teng L, Qiu X, Wang B, Tao J, Yang M, Zhao J, Chen SS, Fan J, Li W, Liu D, He J, Zhong N
J Natl Cancer Cent. 2026 Aug;6(4):379-390 doi: 10.1016/j.jncc.2026.03.003.
Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.
Bo S, Liao Y, Chen X, Liu L, Pang F, Zhou L
3 Biotech. 2026 Aug;16(8):322 doi: 10.1007/s13205-026-04938-1.
Regional differences and influencing factors of needlestick injury protection among clinical nurses in China: a national cross-sectional survey based on economic region.
Shen Y, Liu G, Liu L, Yin Y, Tie H, Shao Y, Liu L, Pu K, Yao H, Jiang X, Wu L, Luo X, Tang W, He R
BMJ Open. 2026 Jul 29;16(7):e107635 doi: 10.1136/bmjopen-2025-107635.

Welcome & Introduction - Dr. Moishe Liberman (Canada) Less is more? Controversies over the interpretation of the final results of JCOG0802 trial - Dr. Shun-ichi Watanabe (Japan) Sublobar vs Lobar Resection for Early Stage Lung Cancer - CALGB 140503 Trial - Dr. Daniel Miller (USA) Can segmentectomy be the standard of care for small-sized NSCLC? Indications and limitations of segmentectomy from the perspective of local recurrence - Dr. Shun-ichi Watanabe (Japan) Addressing Advantages: APAC Expert Consensus Statement - Dr. Lunxu Liu (China) Panel Discussion: Will segmentectomy become standard procedure for early NSLC? How to develop healthcare infrastructure to find early-stage cancer? - All faculty moderated by Dr. Moishe Liberman (Canada) Closing Remarks - Dr. Moishe Liberman (Canada)
With Johnson & Johnson MedTech
Published
Jan 2024

Dr. Piergiorgio Solli, Dr. David Healy, Dr. Lorenzo Rosso, Dr. Robert J Cerfolio, Dr. Marco Scarci, Dr. Scott J. Swanson, Dr. Lunxu Liu, Dr. Haiquan Chen, Dr. Ke-Neng Chen present the congress Global Perspectives: Thoracic Surgery on the Frontline of COVID-19.
With Johnson & Johnson MedTech
Published
Apr 2020
Help your network discover Dr. Lunxu Liu's clinical expertise.